Introducing Xiaflex®, a revolutionary treatment utilized by Dr. Jeffrey S. Williams of Plastic Surgery Associates in Lafayette, LA. This advanced injection can be used to treat conditions such as Dupuytren’s contracture, a slow-developing hand deformity characterized by knots of tissue. Dr. Williams is one of only two surgeons in the entire Acadiana area offering this treatment.
He has received a great deal of praise from his patients affected by the debilitating hand condition, who have been particularly thrilled with the outcome of their treatment.
One such patient, Lynn Thibodeaux suffers from Dupuytren’s Disease, which can create a challenge when managing large objects or performing certain day-to-day functions. For treatment he turned to Dr. Williams who used the advanced Xiaflex® injection to break down the knotted tissue. Like many of Dr. Williams’ patients, Mr. Thibodeaux was very pleased with the exceptional results.
“About two years after developing Dupuytren’s contracture, my primary care doctor recommended the Xiaflex injection to avoid surgery,” said Mr. Thibodeaux. He described himself as “super satisfied” with the results of the injection, which, after a week of therapy left him with “full access and use” of his hands. “I would very much do the treatment again.”
Dr. Williams is also credited locally in the Acadiana area with being the first reconstructive surgeon to perform the groundbreaking DIEP Flap procedure for breast reconstruction after a mastectomy. The sole provider of the cutting-edge procedure in December of 2013, it uses the patient’s abdominal skin and fat to recreate a natural breast, while still preserving the abdominal muscles. The result allows for a faster, less painful recovery period. Additionally, with abdominal muscles still intact, patients experience a lower risk of complications, and are able to maintain long-term core strength.
The Plastic Surgery Associates welcomed Dr. Jeffrey S. Williams to the practice in the Fall of 2013.
Read more about Dr. Williams in the Louisiana Medical News.
One of the least mentioned, but most effective drugs out there is plain ol’ aspirin. It’s rarely mentioned as a first-line defense against cardiovascular disease because…quite frankly…none of the drug companies make a dime from it anymore. It’s generic and dirt cheap. But don’t let the cost fool you. Check out the following summary from my own literature search of publications on the beneficial effects of aspirin.
The Antithrombotic Trialists’ (ATT) Collaboration compiled the results of 6 studies in order to report the benefits and risks of low-dose aspirin to prevent serious vascular events such as myocardial infarction, stroke, or vascular death). Altogether, they studied 95,000 people. They found that taking low-dose aspirin decreases your risk of serious vascular event by 12% per year.(1)
Now the flip side to that is that aspirin can increase your risk of bleeding (gastrointestinal, extracranial). This is something that should be taken into consideration. (1)
Overall, the study found that “in primary prevention without previous disease, aspirin is of uncertain value as the reduction in occlusive events needs to be weighed against any increase in major bleeds.”(1)
So, you may be asking yourself…
How much do I take? 81mg (baby aspirin) once a day.
At what age do I begin taking it? This is a mixed answer, because the risk of cardiovascular disease is different in men and women.
Are there certain medical conditions that would prevent me from taking it?
Yes. Some folks are allergic to aspirin, so this should be avoided in these folks. Next, there are certain conditions, such as stomach ulcers, that may preclude a patient from taking it. If you have any of these conditions, please consult your primary doctor for his ok.
1. Baigent, C., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet, 2009 30;373(9678):1849-60.